{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:17:59Z","timestamp":1787239079226,"version":"build-2736575974"},"reference-count":58,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Public Health Surveill"],"abstract":"<jats:p>The COVID-19 pandemic triggered unprecedented expansion of telemedicine, including in the delivery of opioid agonist treatment (OAT) for people with opioid use disorder (OUD). However, many people with OUD lack the technological resources necessary for remote care, have complex needs, and are underserved, with precarious access to mainstream services. To address the needs of these individuals, we devised a unique program to deliver OAT via telemedicine with the support of community outreach workers in Montreal (Quebec, Canada). The program was co-constructed by the service de m\u00e9decine des toxicomanies of the Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM-SMT)\u2014a hospital-based addiction medicine service\u2014and CACTUS Montr\u00e9al\u2014a community-based harm reduction organization known and trusted by its clientele. All procedures were jointly developed to enable flexible and rapid appointment scheduling. CACTUS Montr\u00e9al workers promoted the program, facilitated private on-site telemedicine connections to the CHUM-SMT, accompanied patients during web-based appointments if requested, and provided ongoing holistic support and follow-up. The CHUM-SMT offered individualized OAT regimens and other health services as needed. Overall, our experience as clinicians and community-based workers intimately involved in establishing and running this initiative suggests that participants found it to be convenient, nonjudgmental, and responsive to their needs, and that the implication of CACTUS Montr\u00e9al was highly valued and integral to patient engagement and retention. Beyond the context of the COVID-19 pandemic, similar programs may present a flexible and accessible means to deliver alternative treatment options for people with OUD disengaged from traditional care, bridge gaps between communities and health providers, and improve access to care in rural or remote settings.<\/jats:p>","DOI":"10.2196\/39236","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T12:59:47Z","timestamp":1686056387000},"page":"e39236","source":"Crossref","is-referenced-by-count":5,"title":["Co-Constructing a Community-Based Telemedicine Program for People With Opioid Use Disorder During the COVID-19 Pandemic: Lessons Learned and Implications for Future Service Delivery"],"prefix":"10.2196","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5403-8341","authenticated-orcid":false,"given":"Stine Bordier","family":"H\u00f8j","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2353-958X","authenticated-orcid":false,"given":"Catherine","family":"de Montigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8135-0982","authenticated-orcid":false,"given":"Sofiane","family":"Chougar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0888-5311","authenticated-orcid":false,"given":"Robert","family":"L\u00e9andre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9800-7860","authenticated-orcid":false,"given":"Marie-\u00c8ve","family":"Beauchemin-Nadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9522-0525","authenticated-orcid":false,"given":"Genevi\u00e8ve","family":"Boyer-Legault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Goyette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2627-5631","authenticated-orcid":false,"given":"Sara-Kim","family":"Lamont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3484-6456","authenticated-orcid":false,"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1089\/15305620252933365"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm.2020.04.188"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30818-7"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2196\/24087"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/2150132720980612"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3603"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1601705"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2021.721898"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-1586"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.dhjo.2020.100973"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.601595"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-020-04623-5"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-016-0487-5"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108627"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1900988"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-8-35"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03140.x"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32229-9"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103127"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103236"},{"key":"ref21","unstructured":"HyshkaEDongKMeadorKSpeedKAbeleBLeBlancSMcFarlaneAMcNeilRSalokangasESchoenEWildTCSupporting people who use substances in shelter settings during the COVID-19 pandemicCanadian Research Initiative in Substance Misuse (Edmonton, Alberta)20202023-06-19https:\/\/crism.ca\/wp-content\/uploads\/2020\/06\/CRISM-Guidance-Supporting-People-Who-Use-Substances-in-Emergency-Shelter-Settings-V1.pdf"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/add.15823"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2020.05.006"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3959(02)00007-5"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.639393"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103088"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108374"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102851"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103237"},{"key":"ref30","unstructured":"Apparent opioid and stimulant toxicity deaths: Surveillance of opioid- and stimulant-related harms in Canada, January 2016 to June 2021Government of Canada2023-06-19Ottawahttps:\/\/publications.gc.ca\/collections\/collection_2021\/aspc-phac\/HP33-7-2021-2-eng.pdf"},{"key":"ref31","year":"2009","journal-title":"Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170958"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30373-X"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/add.15087"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.181506"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.01.020"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1177\/0706743717711167"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2019.305379"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1080\/09687637.2020.1833837"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.54194\/DIGR6414"},{"key":"ref41","unstructured":"SaxeJSubsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in CanadaGovernment of Canada20202022-03-28https:\/\/www.canada.ca\/en\/health-canada\/services\/health-concerns\/controlled-substances-precursor-chemicals\/policy-regulations\/policy-documents\/section-56-1-class-exemption-patients-pharmacists-practitioners-controlled-substances-covid-19-pandemic.html"},{"key":"ref42","unstructured":"BruneauJRehmJWildTWoodESakoASwansburgJLamATelemedicine Support for Addiction Services: National Rapid Guidance DocumentCanadian Research Initiative in Substance Misuse (Montreal, Quebec)20202023-06-19https:\/\/crism.ca\/wp-content\/uploads\/2020\/05\/CRISM-National-Rapid-Guidance-Telemedicine-V1.pdf"},{"key":"ref43","unstructured":"BrarRBruneauJButtPGoyerMLimRPoulinGSeredaARobinsonSRossJWoodEMedications and other clinical approaches to support physical distancing for people who use substances during the COVID-19 pandemic: National Rapid Guidance DocumentCanadian Research Initiative in Substance Misuse (Vancouver, British Columbia)20202023-06-19https:\/\/crism.ca\/wp-content\/uploads\/2020\/06\/CRISM-Guidance-Medications-and-other-clinical-approaches-22062020-final.pdf"},{"key":"ref44","unstructured":"Les t\u00e9l\u00e9consultations r\u00e9alis\u00e9es par les m\u00e9decins durant la pand\u00e9mie de COVID-19: Guide \u00e0 l'intention des m\u00e9decinsColl\u00e8ge des m\u00e9decins du Qu\u00e9bec (Montreal, QC)20202023-06-19https:\/\/numerique.banq.qc.ca\/patrimoine\/details\/52327\/4073726"},{"key":"ref45","unstructured":"Trouble li\u00e9 \u00e0 l\u2019utilisation d\u2019opio\u00efdes (TUO): prescription d\u2019un traitement par agonistes opio\u00efdes (TAO) durant la pand\u00e9mieColl\u00e8ge des m\u00e9decins du Qu\u00e9bec (Montreal, Quebec)2023-06-19http:\/\/www.cmq.org\/page\/fr\/covid-19-trouble-lie-a-l-utilisation-d-opioides-tuo-prescription-d-un-traitement-par-agonistes-opioides-tao-durant-la-pandemie.aspx"},{"key":"ref46","unstructured":"Le traitement du trouble li\u00e9 \u00e0 l\u2019utilisation d\u2019opio\u00efdes: Lignes directrices 03\/2020Coll\u00e8ge des m\u00e9decins du Qu\u00e9bec (Montreal, Quebec)20202023-06-19http:\/\/www.cmq.org\/publications-pdf\/p-1-2020-03-20-fr-le-traitement-du-trouble-lie-a-l-utilisation-d-opioides-tuo.pdf"},{"key":"ref47","unstructured":"GoyerMHudonKPlessis-B\u00e9lairMFergusonYSubstance Replacement Therapy in the Context of the COVID-19 Pandemic in Qu\u00e9bec: Clinical Guidance for PrescribersInstitut universitaire sur les d\u00e9pendances (Montreal, Quebec)20202023-06-19http:\/\/dependanceitinerance.ca\/wp-content\/uploads\/2020\/10\/Guide-Pharmaco-COVID_ANG-VF.19.10.20.pdf"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1949668"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.18223"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51213"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000809"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00572-7"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002969"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-021-00281-3"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108514"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.01.010"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.02.005"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.04.001"}],"container-title":["JMIR Public Health and Surveillance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publichealth.jmir.org\/2023\/1\/e39236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:36:14Z","timestamp":1782840974000},"score":1,"resource":{"primary":{"URL":"https:\/\/publichealth.jmir.org\/2023\/1\/e39236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":58,"URL":"https:\/\/doi.org\/10.2196\/39236","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.39236","asserted-by":"object"}]},"ISSN":["2369-2960"],"issn-type":[{"value":"2369-2960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]}}}